{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "QUALIGEN THER.NEW DL-,001", "longName": "Qualigen Therapeutics, Inc.", "messageBoardId": "finmb_1436301", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.5856222, "regularMarketPrice": 0.931, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1590472800000, "priceHint": 4, "epsTrailingTwelveMonths": -4.07, "sharesOutstanding": 5052460, "bookValue": 2.885, "fiftyDayAverage": 0.9276, "fiftyDayAverageChange": 0.0033999681, "fiftyDayAverageChangePercent": 0.0036653385, "twoHundredDayAverage": 1.907462, "twoHundredDayAverageChange": -0.976462, "twoHundredDayAverageChangePercent": -0.5119169, "marketCap": 4978876, "priceToBook": 0.32270363, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.014999986, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.938, "regularMarketDayRange": "0.931 - 0.938", "regularMarketDayLow": 0.931, "regularMarketVolume": 500, "regularMarketPreviousClose": 0.946, "bid": 0.911, "ask": 0.978, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.938, "averageDailyVolume3Month": 160, "averageDailyVolume10Day": 200, "fiftyTwoWeekLowChange": 0.139, "fiftyTwoWeekLowChangePercent": 0.17550506, "fiftyTwoWeekRange": "0.792 - 5.654", "fiftyTwoWeekHighChange": -4.7229996, "fiftyTwoWeekHighChangePercent": -0.83533776, "fiftyTwoWeekLow": 0.792, "fiftyTwoWeekHigh": 5.654, "earningsTimestamp": 1683059400, "earningsTimestampStart": 1683894600, "earningsTimestampEnd": 1684153800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "7R9.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2042 Corte Del Nogal", "city": "Carlsbad", "state": "CA", "zip": "92011", "country": "United States", "phone": "760 918 9165", "website": "https://www.qualigeninc.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Poirier", "age": 66, "title": "Chairman & CEO", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": {"raw": 583180, "fmt": "583.18k", "longFmt": "583,180"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Amy S. Broidrick", "age": 63, "title": "Pres, Chief Strategy & Operating Officer and Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 457642, "fmt": "457.64k", "longFmt": "457,642"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tariq  Arshad M.B.A., M.D.", "age": 51, "title": "Sr. VP & Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 400138, "fmt": "400.14k", "longFmt": "400,138"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher L. Lotz", "age": 56, "title": "VP of Fin., CFO & Corp. Sec.", "yearBorn": 1966, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Benedict M. Abugan", "title": "VP, Head of Diagnostics & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}